** = Publikationen gelistet in SCI/SSCI/Pubmed
** Deutsch, AJ; Rinner, B; Wenzl, K; Pichler, M; Troppan, K; Steinbauer, E; Schwarzenbacher, D; Reitter, S; Feichtinger, J; Tierling, S; Prokesch, A; Scheideler, M; Krogsdam, A; Thallinger, GG; Schaider, H; Beham-Schmid, C; Neumeister, P
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Blood. 2014; 123(15):2367-2377
Doi: 10.1182/blood-2013-08-518878
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kqiku, X; Kovacs, G; Abdyli, L; Reitter, S; Linkesch, W; Olschewski, H
Screening for early pulmonary vascular changes in patients with chronic myeloproliferative disorders
ONKOLOGIE. 2013; 36: 64-64.
[Poster]
Web of Science
** Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Onkologie. 2012; 35(7-8):447-450
Doi: 10.1159/000340066
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Reitter, S; Rohn, A; Schmidt, HH; Linkesch, W
Upfront radioimmunotherapy represents an effective and safe therapeutic option in cutaneous B-cell non-Hodgkin lymphoma.
Ann Hematol. 2012; 91(1): 129-130.
Doi: 10.1007/s00277-011-1216-1
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, AJA; Pichler, M; Reitter, S; Troppan, K; Beham-Schmid, C; Neumeister, P;
Reduction of NR4A1 is associated with poor survival aggressive lymphomas.
ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart.
[Oral Communication]
Web of Science
** Deutsch, AJA; Rinner, B; Pichler, M; Reitter, S; Beham-Schmid, C; Neumeister, P;
NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model.
BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
Doi: 10.1182/blood.V120.21.2408.2408
[Poster]
Web of Science
FullText
FullText_MUG
** Kqiku, X; Kovacs, G; Reitter, S; Sill, H; Olschewski, H
Screening for pulmonary hypertension in patients with myelodysplastic syndromes
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A22-A23.-Jahrestagung 2011 der Österreichischen Gesellschaft für Pneumologie;
[Poster]
Web of Science
** Reitter, S; Neumeister, P; Beham-Schmid, C; Emberger, W; Strunk, D; Brezinschek, R; Linkesch, W; Schmidt, HH
A case of generalized MALT lymphoma with IgM paraproteinemia and peripheral blood involvement.
Ann Hematol. 2010; 89(2): 213-214.
Doi: 10.1007/s00277-009-0787-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kqiku X; Kovacs G; Reitter S; Sill H; Olschewski H
Prevalence of pulmonary hypertension in myelodysplastic syndrome.
Wien Klin Wochenschr (2010) 122/21-22:A47-A642010; 122: A50-A51.-Jahrestagung 2010 der österreichischen Gesellschaft für Pneumonologie; OCT 7-9, 2010; Graz.
[Poster]
Web of Science
** Reitter, S; Bauer, F; Jager, G; Linkesch, W; Langner, S
Targeted inhibition of angiogenesis suggests a promising therapeutic option in Histiocytic Sarcoma
ONKOLOGIE. 2010; 33: 178-179.
[Poster]
Web of Science
** Scheidl, S; Zinke-Cerwenka, W; Kovacs, G; Reitter, S; Troester, N; Olschewski, H
Bronchiolitis obliterans in allogeneic haematopoietic stem cell transplantation following nonmyeloablative conditioning
AM J RESP CRIT CARE. 2010; 181:
Web of Science
** Sormann, S; Bauer, F; Reitter, S; Pichler, M; Stranzl, T; Dekic, D; Linkesch, W
Results from the Myeloma Registry of the University Hospital Graz
ONKOLOGIE. 2010; 33: 249-250.
[Poster]
Web of Science
** Finke, J; Bethge, WA; Schmoor, C; Ottinger, HD; Stelljes, M; Zander, AR; Volin, L; Ruutu, T; Heim, DA; Schwerdtfeger, R; Kolbe, K; Mayer, J; Maertens, JA; Linkesch, W; Holler, E; Koza, V; Bornhäuser, M; Einsele, H; Kolb, HJ; Bertz, H; Egger, M; Grishina, O; Socié, G; ATG-Fresenius Trial Group
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Lancet Oncol. 2009; 10(9): 855-864.
Doi: 10.1016/S1470-2045(09)70225-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Scheidl, S; Kovacs, G; Zinke-Cerwenka, W; Reitter, S; Kovacs, G; Troester, N; Olschewski, H
Bronchiolitis obliterans in haematopoetic stem cell transplantation following non-myeloablative conditioning
WIEN KLIN WOCHENSCHR. 2009; 121(17-18):A53-A54.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie, ÖGP 2009; JUN 11-13, 2009; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Reitter, S; Posch, U; Eibl, M; Sill, H; Linkesch, W; Zinke-Cerwenka, W
NONMYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RICHTER SYNDROME: A REPORT OF TWO CASES
HAEMATOL-HEMATOL J. 2008; 93: 1410--13th Congress of the European-Hematology-Association; JUN 12-15, 2008; Copenhagen, DENMARK.
[Poster]
Web of Science
** Reitter, S; Zinke-Cerwenka, W; Zebisch, A; Sormann, S; Sill, H; Linkesch, W
Haematopoetic stem cell transplantation in CLL: promising results using allogeneic reduced intensity conditioning compared with an autologous setting
BONE MARROW TRANSPLANT. 2008; 41: S309-S310.-34th Meeting oif the EBMT; MARCH 30- APR 2, 2008; Florence, ITALY.
[Poster]
Web of Science
** Obermayer-Pietsch, BM; Gugatschka, M; Reitter, S; Plank, W; Strele, A; Walter, D; Bonelli, C; Goessler, W; Dobnig, H; Högenauer, C; Renner, W; Fahrleitner-Pammer, A
Adult-type hypolactasia and calcium availability: decreased calcium intake or impaired calcium absorption?
Osteoporos Int. 2007; 18(4): 445-451.
Doi: 10.1007/s00198-006-0251-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Obermayer-Pietsch, BM; Gugatschka, M; Strele, A; Reitter, S; Plank, W; Fahrleitner-Pammer, A; Dobnig, H; Goessler, W; Renner, W
Lactose intolerance and skeletal calcium balance - Decreased calcium intake or impaired calcium resorption?
J BONE MINER RES. 20: S391-S391.-27th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 23-27, 2005; Nashville, TN.
Web of Science